| | Call Details | PerkinElmer Earnings Conference Call (Q4 2012) Scheduled
to start Thu, Jan 31, 2013, 5:00 pm Eastern-- this event is ongoing now--
| | About PerkinElmer Inc
(NYSE:PKI) |
| | PerkinElmer, Inc. provides technology, services, and solutions to the diagnostics, research, environmental, safety and security, industrial and laboratory services markets. PerkinElmer has the portfolios of functional cellular science research technologies, as well as GPCR and kinase products used in researching approximately 75% of drug pathways. The company operates through two segments, Human Health and Environmental Health. The Human Health segment provides early detection for genetic disorders from pre-conception to early childhood, as well as medical imaging for the diagnostics market; and a suite of solutions, including reagents, liquid handling, and detection technologies that enable researchers to improve the drug discovery process. This segment focuses on the cellular research; clinical genetics and diagnostics; cord blood banking and research; drug discovery; life science research and discovery; medical imaging technologies; and pharmaceutical development and manufacturing areas. The Environmental Health segment includes products and services that address the analytical sciences and laboratory service and support markets. This segment focuses on the consumer product safety; environmental analysis; food, flavors, and agricultural analysis; forensic analysis; lubricants and oils; illumination and detection analysis; petrochemical analysis; polymers; renewable energy; and semiconductor and electronics areas. The companys customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. It sells products and accessories primarily through its direct sales force, as well as through distributors. PerkinElmer was founded in 1931 and is headquartered in Waltham, Massachusetts. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|